None of them is FDA-approved for any use, but that might be changing
The trial protocol was approved by the Madrid Region Clinical Research Ethics Committee ( Comit tico de Investigacin Clnica Regional de la Comunidad de Madrid ) on February 8 th 2011, and has been registered with ClinicalTrials.gov number NCT 01476007, and under EUDRACT number 2010-024129-20 [Oral Versus Intramuscular Cobalamin to treat Cobalamin Deficiency: Noninferiority randomised controlled trial, pragmatic and multi-center in the primary healthcare setting (OB12 project)]
However, mild and temporary effects may occasionally occur, including: Most patients experience no side effects only steady, noticeable recovery
Oertel, Christian Cordano, Nour Jabassini, Kirtana Ananth, Apraham Gomez, Azeen Keihani, Makenna Chapman, Sree Javvadi, Shikha Saha, Adam Staffaroni, Christopher Songster, Martin Warren, John W
Companion Supplies & Routine Support Cagrilintide Reconstitution Guide Reconstitution is the process of mixing the lyophilized cagrilintide powder with bacteriostatic water (BAC water) so it becomes injectable